Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Research Abstract |
It is known that pretreatment of minimum amount of lipopolysaccharide(LPS) increases the animals to drug-induced liver injury, otherwise they are hardly affected by drug alone. In addition to previously proposed inflammatory cytokines produced by LPS pre-treatment, we have demonstrated that hepatic GSH decrease is an important factor cooperatively aggravates DILI in this LPS model. Moreover, species difference of the mechanism of hepatic GSH decrease after LPS treatment was emerged ; basolateral efflux of GSH was increased in rat, while metabolic pathway was somehow involved in mouse.
|